Clinical trial
Biomarkers in Head and Neck Cancer - Epigenetic Changes and Hypermethylation of Promoter-regions
NCT04260074 is registered in ClinicalTrials.gov with Aalborg University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biomarkers in Head and Neck Cancer - Epigenetic Changes and Hypermethylation of Promoter-regions
- Lead sponsor
- Aalborg University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 11, 2020
- Completion date
- July 14, 2021
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck cancer, head and neck neoplasms, head and neck squamous cell carcinoma, squamous cell carcinoma